Do Nicoline C, Secher Anna L, Cramon Per, Ringholm Lene, Watt Torquil, Damm Peter, Mathiesen Elisabeth R
Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark.
Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark.
Acta Obstet Gynecol Scand. 2017 Feb;96(2):190-197. doi: 10.1111/aogs.13048. Epub 2016 Dec 1.
The aim of this study was to explore changes in health-related quality of life, anxiety and depression symptoms during pregnancy in women with pregestational diabetes.
An observational cohort study including 137 pregnant women with pregestational diabetes (110 with type 1 and 27 with type 2). To evaluate changes from early to late pregnancy, the internationally validated questionnaires 36-Item Short-Form Health Survey (SF-36) and Hospital Anxiety and Depression Scale (HADS) were completed at 8 and 33 gestational weeks.
From early to late pregnancy, the SF-36 scales Physical Function, Role Physical, Bodily Pain and Physical Component Summary worsened (p < 0.0001 for all scales). Physical Component Summary score deteriorated from mean 52.3 (SD 6.5) to 40.0 (9.7) (p < 0.0001) and the deterioration was negatively associated with gestational weight gain in multiple linear regression (β = -0.34/kg, p = 0.03). The SF-36 scale Mental Health improved (p = 0.0009) and the Mental Component Summary score increased moderately from 47.6 (10.6) to 53.5 (8.6) (p < 0.0001). Greater improvement in Mental Component Summary score was seen with lower HbA1c in late pregnancy. The HADS anxiety score improved slightly from 5.0 (3.3) to 4.5 (3.4) (p = 0.04) whereas the HADS depression score remained unchanged. The prevalence of women with HADS anxiety or depression score ≥8 did not change.
Physical quality of life deteriorated whereas mental quality of life improved slightly during pregnancy in women with pregestational diabetes. A minor reduction in anxiety and stable depression symptoms was observed. The results on mental health are reassuring, considering the great demands that pregnancy places on women with pregestational diabetes.
本研究旨在探讨孕前糖尿病女性在孕期与健康相关的生活质量、焦虑和抑郁症状的变化。
一项观察性队列研究,纳入137例孕前糖尿病孕妇(110例1型糖尿病患者和27例2型糖尿病患者)。为评估孕早期至孕晚期的变化,在孕8周和33周时完成了国际认可的问卷,即36项简短健康调查(SF-36)和医院焦虑抑郁量表(HADS)。
从孕早期到孕晚期,SF-36量表中的身体功能、角色身体、身体疼痛和身体成分总结得分恶化(所有量表p<0.0001)。身体成分总结得分从平均52.3(标准差6.5)降至40.0(9.7)(p<0.0001),且在多元线性回归中,这种恶化与孕期体重增加呈负相关(β=-0.34/kg,p=0.03)。SF-36量表中的心理健康得分有所改善(p=0.0009),心理成分总结得分从47.6(10.6)适度增加至53.5(8.6)(p<0.0001)。孕晚期糖化血红蛋白水平越低,心理成分总结得分改善越明显。HADS焦虑得分从5.0(3.3)略有改善至4.5(3.4)(p=0.04),而HADS抑郁得分保持不变。HADS焦虑或抑郁得分≥8的女性患病率没有变化。
孕前糖尿病女性在孕期身体生活质量恶化,而心理生活质量略有改善。观察到焦虑略有减轻,抑郁症状稳定。考虑到怀孕对孕前糖尿病女性的巨大要求,心理健康方面的结果令人安心。